Posted by Michael Wonder on 03 Feb 2022
COVID-19 vaccine weekly safety report (3 February 2022)
3 January 2022 - To 30 January 2022, the TGA has received 440 reports which have been assessed as likely to be myocarditis from about 33 million doses of Comirnaty (Pfizer) and 49 reports which have been assessed as likely to be myocarditis from about 2.9 million doses of Spikevax (Moderna).
No new cases of vaccine-related thrombosis with thrombocytopenia syndrome have been reported since 16 December 2021.
